F18.20
Inhalant dependence, uncomplicated
Clinical Classification Guidelines
Inclusion Terms
- Inhalant use disorder, moderate
- Inhalant use disorder, severe
Medical Intelligence & Overview
Inhalant dependence, classified under ICD-10 code F18.20, is a condition where a person becomes physically and psychologically reliant on inhalant substances. Inhalants are a diverse group of volatile substances that produce mind-altering effects when inhaled. This dependence can develop after repeated use and may lead to significant health, social, and occupational challenges. Despite being labeled as 'uncomplicated,' inhalant dependence requires awareness and understanding due to its potential risks and the possibility of progressing to more severe substance use disorders.
Causes & Symptoms
Clinical Causes: Repeated inhalation of volatile substances such as solvents, aerosols, gases, and nitrites. Easy availability and low cost of inhalant products, especially among adolescents. Lack of awareness regarding the harmful effects of inhalants. Peer pressure and social environments that promote substance experimentation. Underlying psychological conditions, including stress, depression, or anxiety. Previous exposure to substance use within the family or social circles. Genetic predisposition might influence susceptibility to dependence.
Key Symptoms: Euphoria or a feeling of being 'high' after inhalation. Dizziness, confusion, or slurred speech. Nausea or vomiting. Impaired motor skills and coordination. Headaches and visual disturbances. Mood swings, irritability, or agitation. Cognitive impairments affecting concentration and memory. Unusual breath odors or chemical taste in the mouth. Physical signs such as skin irritation around the nose and mouth. Progressive tolerance leading to increased frequency or dosage of inhalant use.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily clinical, based on reported inhalant use, observed behaviors, and physical signs. Healthcare providers may perform comprehensive assessments, including interviews and physical examinations, to identify signs of dependence. Laboratory tests like blood or urine screens can confirm recent inhalant exposure. It is essential to differentiate uncomplicated inhalant dependence from more severe or complicated forms, which might involve additional mental health conditions or medical issues.
Treatment Protocols: Treatment strategies focus on detoxification, psychological support, and behavioral therapies. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is F18.20 a billable ICD-10 code?
Yes, F18.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.20?
Clinical documentation must specify the nature of Inhalant dependence, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference